Laurence Reilly

Direttore/Membro del Consiglio presso IMMUPHARMA PLC

42 anni

Health Technology

Consumer Services

Profilo

Laurence Reilly is currently a Senior Independent Non-Executive Director at ImmuPharma Plc and a Vice President-Research & Investments at Royalty Pharma Plc.
He previously worked as the Chief Scientific Officer & Vice President at Avillion LLP and as the Chief Medical Officer at Cellectar Biosciences, Inc. Reilly holds a doctorate degree from The University of Liverpool and a graduate degree from De Montfort University.

Posizioni attive di Laurence Reilly

Società	Posizione	Inizio
IMMUPHARMA PLC	Direttore/Membro del Consiglio	11/08/2023
ROYALTY PHARMA PLC	Corporate Officer/Principal	-

Tutte le posizioni attive di Laurence Reilly

Precedenti posizioni note di Laurence Reilly

Società	Posizione	Fine
Avillion LLP Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.	Direttore Tecnico/Scientifico/R&S	-
CELLECTAR BIOSCIENCES, INC.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Laurence Reilly

Formazione di Laurence Reilly

De Montfort University	Graduate Degree
The University of Liverpool	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Laurence Reilly

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
CELLECTAR BIOSCIENCES, INC.	Health Technology
IMMUPHARMA PLC	Health Technology
ROYALTY PHARMA PLC	Health Technology

Aziende private	1
Avillion LLP Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.	Health Technology